Hutchinson-Gilford progeria syndrome: Rejuvenating old drugs to fight accelerated ageing - Sorbonne Université Access content directly
Journal Articles Methods Year : 2020

Hutchinson-Gilford progeria syndrome: Rejuvenating old drugs to fight accelerated ageing

Abstract

What if the next generation of successful treatments was hidden in the current pharmacopoeia? Identifying new indications for existing drugs, also called the drug repurposing or drug rediscovery process, is a highly efficient and low-cost strategy. First reported almost a century ago, drug repurposing has emerged as a valuable therapeutic option for diseases that do not have specific treatments and rare diseases, in particular. This review focuses on Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that induces accelerated and precocious aging, for which drug repurposing has led to the discovery of several potential treatments over the past decade.
Fichier principal
Vignette du fichier
1-s2.0-S1046202319303020-main.pdf (1.74 Mo) Télécharger le fichier
Origin Publication funded by an institution
Loading...

Dates and versions

hal-02548462 , version 1 (20-04-2020)

Identifiers

Cite

Solenn M Guilbert, Déborah Cardoso, Nicolas Lévy, Antoine Muchir, Xavier Nissan. Hutchinson-Gilford progeria syndrome: Rejuvenating old drugs to fight accelerated ageing. Methods, 2020, ⟨10.1016/j.ymeth.2020.04.005⟩. ⟨hal-02548462⟩
187 View
189 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More